Nicotine |
||
Saturday, 13 April 2002 |
||
Organizer |
L. Galanti (Yvoir, Belgium) | |
Sponsor |
GlaxoSmithKline | |
Tobacco addiction: from nicotine receptorsto smoking cessation |
||
Session I |
Abstract no
|
|
Chairs | J. Prignot (Brussels, Belgium) L. Galanti (Yvoir, Belgium) |
|
11.00 – 11.15 |
Utilization of a structured record in the smoking cessation process J. Dumont (Brussels, Belgium) |
|
11.15 – 11.45 |
In utero exposure to heavy maternal smoking induces nicotine withdrawal symptoms in neonates V. Godding, C. Bonnier, L. Fiasse, M. Michel, E. Longueville, and L. Galanti (Brussels, Belgium) |
150
|
11.45 – 12.15 |
Anxiety, Nesbit’s paradox and smoking R. Molimard (Paris, France) |
|
12.15 – 12.30 |
Nicotinic receptors involved in bleomycin induced apoptosis D. Gimonet, P. Coninx, F. Antonicelli, B. Haye, and F. Liautaud-Roger (Reims, France) |
148
|
12.30 – 13.00 | discussion and end of session | |
13.00 – 14.00 | lunch and poster viewing | |
Session II |
Saturday, 13 April 2002 | |
Chairs | P. Bartsch (Liège, Belgium)V. Godding (Brussels, Belgium) |
Abstract no
|
14.00 – 14.30 |
Tobacco addiction: from nicotine receptors to smoking cessation K. Fagerström (Helsingborg, Sweden) |
|
14.30 – 15.00 |
Neuronal nicotinic receptors : from structure to function J. Le Houezec (Paris, France) |
|
15.00 – 15.30 |
Smoking effects on brain functional imaging T. Vander Borght (Yvoir, Belgium) |
149
|
15.30 – 16.00 | coffee break | |
16.00 – 16.30 |
Nicotine and bupropion, the unique pharmacological approach of smoking cessation? P. Bartsch (Liège, Belgium) |
|
16.30 – 17.00 |
Smoking reduction – Harm reduction? J. Prignot (Brussels, Belgium) |
|
17.00 – 17.30 | discussion and end of session | |
17.30 | end of workshop 17 | |
Workshop 17 Posters |
Abstract no |
Tobacco withdrawal looked as a mourning process J. Coulon, and A. Grivegnée (Brussels, Belgium.) |
151
|